Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| CG Oncology, Inc.(CGON) | 2,221,474 | 2,221,474 | 0 | $63.71M | $54.40M | 29.80% | -$9.31M |
| Alumis Inc | 4,202,670 | 4,202,670 | 0 | $33.03M | $25.80M | 14.14% | -$7.23M |
| Centessa Pharmaceuticals IncADS | 1,253,379 | 1,253,379 | 0 | $20.99M | $18.02M | 9.87% | -$2.97M |
| Rapt Therapeutics Inc | 12,500,000 | 12,500,000 | 0 | $19.75M | $15.25M | 8.35% | -$4.50M |
| Akero Therapeutics Inc | 365,000 | 365,000 | 0 | $10.15M | $14.78M | 8.09% | +$4.62M |
| Edgewise Therapeutics, Inc.(EWTX) | 585,000 | 585,000 | 0 | $15.62M | $12.87M | 7.05% | -$2.75M |
| Bicara Therapeutics Inc | 950,000 | 950,000 | 0 | $16.55M | $12.38M | 6.78% | -$4.17M |
| Structure Therapeutics IncADS | 420,000 | 420,000 | 0 | $11.39M | $7.27M | 3.98% | -$4.12M |
| Allogene Therapeutics Inc | 3,448,275 | 3,448,275 | 0 | $7.34M | $5.03M | 2.76% | -$2.31M |
| Corvus Pharmaceuticals, Inc.(CRVS) | 1,581,233 | 1,581,233 | 0 | $8.46M | $5.03M | 2.75% | -$3.43M |
| Cullinan Therapeutics, Inc.(CGEM) | 634,558 | 634,558 | 0 | $7.73M | $4.80M | 2.63% | -$2.93M |
| Kymera Therapeutics, Inc.(KYMR) | 146,332 | 146,332 | 0 | $5.89M | $4.01M | 2.19% | -$1.88M |
| CASI Pharmaceuticals, Inc.(CASIF) | 1,329,383 | 1,329,383 | 0 | $3.76M | $2.87M | 1.57% | -$890.7K |
| Viridian Therapeutics, Inc.(VRDN) | 1,974 | 1,974 | 0 | $37.8K | $26.6K | 0.01% | -$11.2K |